|
US3853893A
(en)
*
|
1973-04-02 |
1974-12-10 |
Squibb & Sons Inc |
Anthelmintic 5-(pyridyl)-3-(isothiocyanophenyl) oxadiazoles
|
|
HU177086B
(en)
*
|
1975-06-09 |
1981-07-28 |
Eszakmagyar Vegyimuevek |
Herbicide and fungicide preparation containing substituted 1,2,4-oxadiazolidin-3-one derivatives
|
|
JPS58150576A
(ja)
*
|
1982-03-03 |
1983-09-07 |
Sumitomo Chem Co Ltd |
新規な１，２，４−オキサジアゾ−ル誘導体
|
|
DE3247118A1
(de)
*
|
1982-12-20 |
1984-06-20 |
Cassella Ag, 6000 Frankfurt |
Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
|
US6660753B2
(en)
*
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
ATE307129T1
(de)
*
|
1999-08-19 |
2005-11-15 |
Nps Pharma Inc |
Heteropolycyclische verbindungen und ihre verwendung als antagonisten von metabotropen glutamatrezeptoren
|
|
EP1582519A3
(en)
*
|
1999-08-19 |
2005-12-21 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
PL369598A1
(en)
*
|
2001-02-21 |
2005-05-02 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
US7074809B2
(en)
|
2002-08-09 |
2006-07-11 |
Astrazeneca Ab |
Compounds
|
|
CA2520255C
(en)
*
|
2003-04-09 |
2014-07-08 |
Exelixis, Inc. |
Tie-2 modulators and methods of use
|
|
WO2004103279A2
(en)
*
|
2003-05-15 |
2004-12-02 |
Merck & Co., Inc. |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
|
|
US20060189661A1
(en)
*
|
2003-11-03 |
2006-08-24 |
Wagenen Bradford V |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
WO2005060961A2
(en)
*
|
2003-12-18 |
2005-07-07 |
Astrazeneca Ab |
Treatment of transient lower esophageal sphincter relaxations (tlesrs) and gastro-esophageal reflux disease (gerd)
|
|
NZ547965A
(en)
*
|
2003-12-24 |
2009-12-24 |
Prosidion Ltd |
1,2,4-Oxadiazole derivatives as GPCR receptor agonists
|
|
WO2005077368A2
(en)
*
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
JP2008539195A
(ja)
*
|
2005-04-26 |
2008-11-13 |
ノイロサーチ アクティーゼルスカブ |
新規のオキサジアゾール誘導体及びそれらの医学的使用
|
|
IL169855A
(en)
*
|
2005-07-25 |
2014-05-28 |
Elta Systems Ltd |
A system and method for locating a receiver location
|
|
SI1907382T1
(sl)
|
2005-07-26 |
2015-10-30 |
Bial-Portela & Ca S.A., |
Nitrokateholni derivati kot inhibitorji COMT
|
|
EP1845097A1
(en)
*
|
2006-04-10 |
2007-10-17 |
Portela & Ca., S.A. |
Oxadiazole derivatives as COMT inhibitors
|
|
MY149853A
(en)
*
|
2006-09-07 |
2013-10-31 |
Actelion Pharmaceuticals Ltd |
Pyridin-4-yl derivatives as immunomodulating agents
|
|
AR062684A1
(es)
*
|
2006-09-08 |
2008-11-26 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de piridin-3- ilo, composicion farmaceutica que los contiene, y uso de los mismos en la preparacion de medicamentos
|
|
ES2597705T3
(es)
*
|
2007-01-31 |
2017-01-20 |
Bial - Portela & Ca., S.A. |
Derivados de nitrocatecol como inhibidores de COMT administrados con un régimen de dosificación específico
|
|
DK2125797T3
(da)
*
|
2007-03-16 |
2014-02-10 |
Actelion Pharmaceuticals Ltd |
Aminopyridinderivater som s1p1/edg1-receptoragonister
|
|
HRP20110449T1
(hr)
*
|
2007-08-17 |
2011-07-31 |
Actelion Pharmaceuticals Ltd. |
Derivati piridina kao modulatori receptora s1p1/edg1
|
|
EP2259777A2
(en)
*
|
2008-02-28 |
2010-12-15 |
BIAL - Portela & Ca., S.A. |
Pharmaceutical composition for poorly soluble drugs
|
|
CA2714665A1
(en)
*
|
2008-03-06 |
2009-09-11 |
Actelion Pharmaceuticals Ltd |
Pyridine compounds
|
|
JP5435745B2
(ja)
*
|
2008-03-07 |
2014-03-05 |
アクテリオン ファーマシューティカルズ リミテッド |
免疫調節剤としてのピリジン−２−イル誘導体
|
|
EP2276758B1
(en)
|
2008-03-17 |
2016-01-06 |
Bial-Portela & CA, S.A. |
Crystal forms of 5- [3- (2, 5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl) [1,2,4] oxadiazol-5-yl]-3-nit robenzene-1, 2-diol
|
|
PL2291080T3
(pl)
*
|
2008-05-14 |
2015-12-31 |
Scripps Research Inst |
Nowe modulatory receptorów sfingozyno-1-fosforanu
|
|
ES2754503T3
(es)
|
2009-02-10 |
2020-04-17 |
Monsanto Technology Llc |
Composiciones y procedimientos de lucha contra nematodos
|
|
AU2010231962B2
(en)
*
|
2009-04-01 |
2015-05-21 |
Bial - Portela & Ca., S.A. |
Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
|
|
KR102329271B1
(ko)
*
|
2009-04-01 |
2021-11-22 |
바이알 - 포르텔라 앤드 씨에이 에스에이 |
니트로카테콜 유도체를 포함하는 제약 제제 및 그의 제조 방법
|
|
KR101409131B1
(ko)
|
2009-07-16 |
2014-06-17 |
액테리온 파마슈티칼 리미티드 |
피리딘-4-일 유도체
|
|
WO2012098505A1
(en)
|
2011-01-19 |
2012-07-26 |
Actelion Pharmaceuticals Ltd |
2-methoxy-pyridin-4-yl derivatives
|
|
US20140045900A1
(en)
|
2011-02-11 |
2014-02-13 |
Bial-Portela & Ca, S.A. |
Administration regime for nitrocatechols
|
|
PL2791134T3
(pl)
|
2011-12-13 |
2020-03-31 |
BIAL - PORTELA & Cª S.A. |
Związek chemiczny użyteczny jako związek pośredni do wytwarzania inhibitora katechol-o-metylotransferazy
|
|
US9232800B2
(en)
*
|
2013-02-15 |
2016-01-12 |
Monsanto Technology Llc |
3,5-disubstituted-4,5-dihydro-1,2,4-oxadiazoles and compositions and methods for controlling nematode pests
|
|
RU2017120184A
(ru)
|
2014-11-28 |
2018-12-28 |
БИАЛ - ПОРТЕЛА ЭНД Ка, С.А. |
Лекарства для замедления течения болезни паркинсона
|
|
EP3298008B1
(en)
|
2015-05-20 |
2019-11-20 |
Idorsia Pharmaceuticals Ltd |
Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol
|